|
Facebook
Twitter
Linkedin
|
Toshiba gets FDA clearance
| Company News - Toshiba Medical Systems Corporation |
Toshiba announces FDA clearance for new Vantage Atlas MRI system
Toshiba America Medical Systems, Inc. announced at RSNA that the Food and Drug Administration has cleared for market its new EXCELART VantageTM powered by Atlas 1.5T magnetic resonance imaging (MRI) system.
The Vantage Atlas 1.5T MRI system features a complete redesign of the system. The new 128-element system will meet clinical demands for an MRI system that delivers high-resolution images across the entire body with faster imaging times, rendering quick and accurate diagnosis, and will increase patient comfort. The new Atlas system design is an integrated coil concept that will allow clinicians to perform multiple exams without repositioning the patient. This will mean more comfortable exam experiences and will result in enhanced workflow and technologist productivity. Also, the Vantage Atlas' optional 205-cm acquisition range allows for feet-first imaging for the entire body, except the neck and head.
"The Vantage Atlas features state-of-the-art technology and is designed with exceptional patient care and comfort in mind," said Bob Giegerich, director, MR Business Unit, Toshiba. "The system not only decreases imaging time and broadens future upgrade capabilities, its imaging quality is second-to-none."
With Toshiba's patented PianissimoTM technology, the Vantage dramatically reduces acoustic noise, the most significant cause of patient discomfort during an MRI exam, and enables clinicians to better utilize all of the system's high-field MRI capabilities.
The Vantage Atlas 1.5T MRI system features a complete redesign of the system. The new 128-element system will meet clinical demands for an MRI system that delivers high-resolution images across the entire body with faster imaging times, rendering quick and accurate diagnosis, and will increase patient comfort. The new Atlas system design is an integrated coil concept that will allow clinicians to perform multiple exams without repositioning the patient. This will mean more comfortable exam experiences and will result in enhanced workflow and technologist productivity. Also, the Vantage Atlas' optional 205-cm acquisition range allows for feet-first imaging for the entire body, except the neck and head.
"The Vantage Atlas features state-of-the-art technology and is designed with exceptional patient care and comfort in mind," said Bob Giegerich, director, MR Business Unit, Toshiba. "The system not only decreases imaging time and broadens future upgrade capabilities, its imaging quality is second-to-none."
With Toshiba's patented PianissimoTM technology, the Vantage dramatically reduces acoustic noise, the most significant cause of patient discomfort during an MRI exam, and enables clinicians to better utilize all of the system's high-field MRI capabilities.











